Regular Article
Disruption of Androgen-Regulated Male Reproductive Development by Di(n-Butyl) Phthalate during Late Gestation in Rats Is Different from Flutamide

https://doi.org/10.1006/taap.1999.8643Get rights and content

Abstract

Gestational and lactational exposure to di(n-butyl) phthalate (DBP) at ≥250 mg/kg/day disrupts male rat reproductive development and function. Although this indicates an antiandrogenic mechanism, DBP and its biologically active metabolite do not interact with the androgen receptor (AR)in vitro.In the present study, we compared the effects of DBP and the antiandrogen flutamide using a shorter exposure during the prenatal period of male sexual differentiation in rats. Pregnant CD rats received DBP at 0, 100, 250, or 500 mg/kg/day po (n= 10) or flutamide at 100 mg/kg/day po (n= 5) from Gestation Days 12 to 21. In F1males, DBP (500 mg/kg/day) and flutamide caused hypospadias; cryptorchidism; agenesis of the prostate, epididymis, and vas deferens; degeneration of the seminiferous epithelium; and interstitial cell hyperplasia of the testis. Flutamide and DBP (250 and 500 mg/kg/day) also produced retained thoracic nipples and decreased anogenital distance. Interstitial cell adenoma occurred at 500 mg DBP/kg/day in two males. The only effect seen at 100 mg DBP/kg/day was delayed preputial separation. In contrast to flutamide, DBP caused a low incidence of prostate agenesis and hypospadias with no vaginal pouch. The low incidence of DBP-induced intraabdominal testes contrasted with the high incidence of inguinal testes seen with flutamide. Thus prenatal male sexual differentiation is a sensitive period for the reproductive toxicity of DBP. A no observed adverse effect level was not established and the lowest observed (adverse) effect level was 100 mg/kg/day. Flutamide and DBP disrupted the androgen signaling necessary for male sexual differentiation but with a different pattern of antiandrogenic effects. DBP is an example of an environmental antiandrogen that disrupts androgen-regulated male sexual differentiation without interacting directly with the AR, as does flutamide.

References (37)

  • P. Lindstrom et al.

    Comparison of changes in serum androgen binding protein with germinal epithelial damage and infertility by di-n

    Fundam. Appl. Toxicol.

    (1988)
  • S.C. Maness et al.

    Inhibition of androgen receptor-dependent transcriptional activity by DDT isomers and methoxychlor in HepG2 human hepatoma cells

    Toxicol. Appl. Pharmacol.

    (1998)
  • E. Mylchreest et al.

    Male reproductive tract malformations in rats following gestational and lactational exposure to di(n

    Toxicol. Sci.

    (1998)
  • T. Shono et al.

    The effect of flutamide on testicular descent in rats examined by scanning electron microscopy

    J. Pediatr. Surg.

    (1994)
  • G.A. Boorman et al.

    Focal interstitial cell hyperplasia, testes, rat

    Genital System

    (1987)
  • L.E. Gray et al.

    Dibutyl phthalate (DBP) induces antiandrogenic but not estrogenicin vivo

    Toxicol. Sci.

    (1998)
  • C.A. Harris et al.

    The estrogenic activity of phthalate estersin vitro

    Environ. Health Perspect.

    (1997)
  • J.M. Hutson et al.

    Anatomical and functional aspects of testicular descent and cryptorchidism

    Endocr. Rev.

    (1997)
  • Cited by (0)

    T. C. JonesU. MohrR. D. Hunt

    View full text